Brexucabtagene Autoleucel

brexucabtagene autoleucel · Kite Pharma (Gilead)

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Brexucabtagene Autoleucel, covering 2022-05-10 to 2026-08-18. Get the full timeline:

Most recent: Clinical Trial Results: Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3) [Phase 2]

See pricing